Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Sergio Traversa Net Worth & Insider Trades

Sergio Traversa - Director, Actinium Pharmaceuticals, Inc

As of March 16, 2017

What is Sergio Traversa's Net Worth?

The current estimated net worth of Actinium Pharmaceuticals, Inc's Director, Sergio Traversa, is estimated to be about $2.53M . Sergio Traversa owns about 3,000 units of Actinium Pharmaceuticals, Inc common stock. In the last 4 years at Actinium Pharmaceuticals, Inc, Sergio Traversa has sold an estimated value of $0 worth.

What is Sergio Traversa's Past Insider Trading?

Sergio Traversa's largest purchase order was 3,000 units , worth over $6.06K on April 18, 2016. In total, Sergio Traversa has made about 4 transactions over 4 years of their time at Actinium Pharmaceuticals, Inc. Sergio Traversa usually trades in March, with the busiest year in 2016, 2013, 2017 and 2015.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sergio Traversa

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Sergio Traversa's' Mailing Address?

  • Mailing address is 138 Canterbury Ln Blue Bell PA 19422 PA

What are Actinium Pharmaceuticals, Inc's Past Insider Trades?

Actinium Pharmaceuticals, Inc's most recent insider trade came on December 10, 2018 by Sandesh Seth who bought 10,000 units worth $4.37K . In the last 5 years, insiders at Actinium Pharmaceuticals, Inc have sold an estimated value of $2.28M and bought an estimated value of $315.67K worth of shares. Insider trading is most common in July, with the busiest year in 2016. The most active traders at the company are Sandesh Seth, Chief Executive Officer,  Memorial Sloan-Kettering Cancer Center,  and Richard Steinhart, Director .

Actinium Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...